Table 1.

Clinical performance of AccuPower SARS-CoV-2 Multiplex RT-PCR kit and Allplex 2019-nCoV Assay using the CDC protocol as a gold standard (% values: sensitivity).

RT-PCR kit	Positive samples (including “presumptive positive: samples)	False-negative samples	Total SARS-CoV-2 positive samples
Allplex 2019-nCoV Assay	55 (96.5%)	2	57
AccuPower SARS-CoV-2 Multiplex RT-PCR kit	37 (75.5%)	12	49

Only SARS-CoV-2 positive samples included on the study are detailed.